import { Article } from "../../lib/types";
import f027_001 from "./article_images/f027_001.png";
import f027_002 from "./article_images/f027_002.png";
import f027_003 from "./article_images/f027_003.png";
import f027_004 from "./article_images/f027_004.png";
import f027_005 from "./article_images/f027_005.png";
import f027_006 from "./article_images/f027_006.png";
import f027_007 from "./article_images/f027_007.png";
import f027_008 from "./article_images/f027_008.png";
import f027_009 from "./article_images/f027_009.png";

const article: Article = {
  id: "RK-2026-027",
  title: "DNA-drug interactions",
  date: "2026-03-03",
  tags: ["#DNA", "#Drug", "#Natural-Products"],
  type: "report",
  template: "standard",
  readTime: "30 min",
  author: {
    name: "RK Patel",
    role: "Microbiologist",
    avatar: "https://github.com/RKPatel-1996.png",
    affiliation: "Gujarat University",
  },
  excerpt: `
    
`,
  content: `


<article>
<h2>1. DNA Structural Polymorphism</h2>

<p>DNA is a highly <dfn>polymorphic</dfn> molecule—meaning it is capable of existing in<b> multiple distinct physical forms</b>. It is precisely this immense structural diversity that makes it an exceptionally versatile target for pharmacological intervention.</p> <p>The susceptibility of DNA to various drugs arises from....<ul><li>its primary sequence of bases</li> <li>its distinct topographical features (the 3D landscape of the molecule),</li> <li>its dynamic ability to fold into complex, higher-order architectures under specific cellular conditions.</li></ul> </p>

<p>Here are the various structural and complex properties of DNA that render it susceptible to drug interactions:</p>

<h3>1.1 Double Helix and Asymmetrical Grooves</h2>


<figure class="science-figure" data-id="Figure: 1" data-clean-src="${f027_001}">
  <img src="${f027_001}" alt="3D model highlighting the major and minor grooves of a B-DNA double helix" />
  <figcaption>The asymmetrical attachment of base pairs to the sugar-phosphate backbone naturally creates the distinct major and minor grooves in B-DNA.</figcaption>
</figure>

<p>The most stable and common form of DNA under standard physiological conditions is the right-handed <strong>B-DNA</strong> double helix. Because the <dfn>glycosidic bonds</dfn> (the chemical links connecting the nitrogenous nucleobases to the sugar-phosphate backbone) are not diametrically opposed (exactly 180 degrees apart), the natural twisting of the helix forms two distinct, asymmetrical spiral cavities:</p>

<h4>1.1.1 The Major Groove</h4>
<p>At approximately 12 Å (Angstroms) wide, the major groove is spacious enough to easily accommodate bulky drug molecules and large regulatory proteins. It exposes a rich array of hydrogen bond donors and acceptors. This includes highly <dfn>nucleophilic</dfn> (electron-rich and reactive) atoms, such as the N7 and O6 atoms of the guanine base, and the O4 atom of thymine, making it a prime site for chemical docking.</p>

<h4>1.1.2 The Minor Groove</h4>

<figure class="science-figure" data-id="Figure: 2" data-clean-src="${f027_002}">
  <img src="${f027_002}" alt="crescent-shaped drug molecules (" />
  <figcaption>The crescent-shaped drug molecules that binds with minor grooves in B-DNA.</figcaption>
</figure>
<p>At approximately 6 Å wide, the minor groove is significantly narrower. It serves as a highly specific binding pocket for smaller, crescent-shaped drug molecules (such as the antibiotics netropsin and distamycin). These drugs are perfectly curved to seamlessly wrap along the convex floor of the groove.</p>


<h3>1.2. Nucleobase Composition and Steric Features</h3>

<p>The specific sequence of the purine (Adenine, Guanine) and pyrimidine (Thymine, Cytosine) bases strictly dictates where a drug can physically and chemically bind.</p>

<h4>1.2.1 A-T Rich Regions</h4>
<p>The minor groove in regions rich with Adenine-Thymine (A-T) base pairs is uniquely narrow. It features highly electronegative pockets that are ideal for forming <strong>van der Waals contacts</strong> (distance-dependent weak physical attractions) and hydrogen bonds with specific, perfectly shaped minor groove-binding drugs.</p>

<h4>1.2.2 G-C Rich Regions</h4>
<p>In regions rich with Guanine-Cytosine (G-C) base pairs, the minor groove is physically obstructed. The <b>2-amino group of the guanine base physically protrudes</b> directly into the minor groove space. This creates <dfn>steric hindrance</dfn>—a spatial blockade that physically prevents many minor groove binders from attaching.</p>

<p>Because of this steric blockade in the minor groove, <b>G-C rich regions are predominantly targeted </b>by drugs via the spacious <b>major groove</b>. This is particularly true for covalent alkylating agents and metal-based drugs (like cisplatin), which readily coordinate with the exposed, highly reactive N7 position of the guanine bases found there.</p>

<h3>1.3. Alternative Helical Conformations</h3>

<figure class="science-figure" data-id="Figure 3" data-clean-src="${f027_003}">
  <img src="${f027_003}" alt="Side-by-side structural comparison of A-DNA, B-DNA, and Z-DNA" />
  <figcaption> DNA is a dynamic polymer. Depending on hydration and sequence, it can shift from standard B-DNA into dramatically different conformations like A-DNA and Z-DNA.</figcaption>
</figure>

<p>While B-DNA is the standard, biological DNA is highly dynamic and can transition into other helical forms depending on environmental conditions (like cellular dehydration) or superhelical stress (tight twisting during replication), creating unique drug targets:</p>

<p><b>A-DNA</b> is a dehydrated, wider, and much flatter right-handed helix. Unlike B-DNA, it contains a distinctly<b> hollow central core and heavily altered groove dimensions</b>, shifting how drugs might interact with the helix.</p>

<p><b>Z-DNA</b> is a radical departure from the norm: it is a <em>left-handed</em> helix characterized by a rigid, zig-zagging sugar-phosphate backbone. Z-DNA completely <b>lacks a traditional major groove</b>, but it<b> possesses a deep, narrow minor groove that extends all the way down to the molecule's central axis</b>. It typically forms in genomic sequences with alternating purines and pyrimidines and is highly associated with the biological regulation of gene expression.</p>

<h3>1.4. Higher-Order, Non-Canonical Architectures</h3>

<p>A major frontier in modern targeted therapy is the exploitation of complex, three-dimensional DNA knots and junctions. These structures form temporarily during DNA replication, transcription, or act as permanent "switches" in specific regulatory genes.</p>

<h4>1.4.1 G-Quadruplexes (G4s)</h4>
<figure class="science-figure" data-id="Figure 4" data-clean-src="${f027_004}">
  <img src="${f027_004}" alt="Structural hierarchy of G-Quadruplexes from chemical bonds to 3D folding" />
  <figcaption><strong> Structural features and topologies of G-Quadruplexes.</strong> (A) A single G-tetrad formed by four guanine bases via Hoogsteen hydrogen bonding, coordinated by a central metal cation (green). (B) Schematic representations of various G4 folding topologies (parallel, antiparallel, and mixed loops). (C) Top and side 3D molecular views of a stacked G4 core. (D) A higher-order G4 structure stabilized by an inner channel of ions. (E) A G-quadruplex motif shown continuous with a standard Watson-Crick double helix, illustrating the dramatic structural shift.</figcaption>
</figure>


<p>In guanine-rich regions of the genome—such as at the very ends of chromosomes (telomeres) and the promoters (on-switches) of aggressive oncogenes like MYC, KRAS, and BCL-2—the DNA strand can fold back on itself to form compact, four-stranded structures. These are built from planar "G-tetrads" held together by <strong>Hoogsteen hydrogen bonds</strong> (an alternative base-pairing mechanism that utilizes different atomic faces than standard Watson-Crick pairing). They are heavily stabilized by central Potassium (K<sup>+</sup>) or Sodium (Na<sup>+</sup>) cations. G4s possess immense structural diversity (forming parallel, antiparallel, or mixed topologies with vacancy gaps), allowing specialized drugs like <b>berberine</b> or <b>telomestatin</b> to highly selectively recognize, bind, and "lock" these structures to silence the cancer-driving genes.</p>


<h4>1.4.2 i-Motifs</h4>
<figure class="science-figure" data-id="Figure 5" data-clean-src="${f027_005}">
  <img src="${f027_005}" alt="Schematic showing equilibrium between DNA double helix, G-quadruplex, and i-motif structures with chemical callouts." />
  <figcaption><strong>Equilibrium between double-stranded DNA and non-canonical G-quadruplex/i-motif structures.</strong> The schematic shows a G-rich strand folding into a G-quadruplex (G4, left) and its complementary C-rich strand folding into an i-motif (iM, right), often in dynamic equilibrium with the standard double helix. Callout boxes illustrate the specific Hoogsteen hydrogen bonding patterns stabilizing these structures: planar G-tetrads (red highlight) for the G4 and hemiprotonated C:C+ base pairs (green highlight) for the iM.</figcaption>
</figure>
<p>Found primarily in cytosine-rich sequences, i-motifs are complex four-stranded structures that are heavily influenced by the surrounding cellular pH. They act as dynamic, pH-dependent switches linked to critical gene regulation.</p>

<h4>1.4.3 Triple Helices (H-DNA)</h4>
<p>In tracts of DNA consisting entirely of purines or entirely of pyrimidines, a third oligonucleotide strand can seamlessly bind within the spacious major groove of the existing double helix, utilizing Hoogsteen or reverse-Hoogsteen base pairing. Researchers actively exploit this to design <strong>Triplex-Forming Oligonucleotides (TFOs)</strong>—synthetic strands designed to deliver attached DNA-damaging agents to highly specific, targeted genomic sequences.</p>

<h4>1.4.4 DNA Junctions</h4>
<p>During fundamental processes like DNA replication and homologous repair (fixing broken strands), DNA strands temporarily separate and cross over one another. This forms Three-Way Junctions (3WJ) and four-way Holliday Junctions (HJ). These cross-structures feature unique, highly hydrophobic (water-repelling) cavities at their branch points. Small molecules (like bis-acridines or complex organometallic helicates) can specifically wedge into the "open-X" or "stacked-X" cores of these junctions. This prevents the DNA from resolving properly back into standard double helices, intentionally causing toxic genomic instability and death in rapidly dividing cancer cells.</p>


<h3>1.5. The Electrostatic Sugar-Phosphate Backbone</h3>

<p>The fundamental structural backbone of the DNA polymer is composed of repeating phosphate groups. Because phosphates carry a negative charge, the entire DNA molecule is a massive, highly negatively charged <dfn>polyanion</dfn>.</p>

<p>This creates a massive electrostatic attraction for positively charged (cationic) <dfn>xenobiotics</dfn> (foreign chemical substances, including drugs) and heavy metal complexes. While electrostatic attraction is rarely the sole therapeutic mechanism of action, this powerful magnetic-like pull acts as a crucial preliminary anchor. It forcefully draws the drug out of the watery cellular environment and onto the DNA molecule's surface, perfectly positioning the drug so it can subsequently intercalate, dock into a groove, or form irreversible covalent cross-links.</p>


<h3>1.6 Summary of DNA Drug Targets</h3>

<table class="science-table" data-id="table1">
  <caption>Table 1: Summary of DNA Structural Features and Associated Drug Interactions.</caption>
  <thead>
    <tr>
      <th>Structural Feature</th>
      <th>Key Characteristics</th>
      <th>Typical Drug Interaction</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><strong>Major Groove</strong></td>
      <td>Spacious (~12 Å), rich in nucleophilic sites (e.g., N7 Guanine).</td>
      <td>Covalent alkylation, metal coordination, large proteins/drugs.</td>
    </tr>
    <tr>
      <td><strong>Minor Groove</strong></td>
      <td>Narrow (~6 Å), A-T rich preference due to lack of steric hindrance.</td>
      <td>Non-covalent docking of small, crescent-shaped molecules.</td>
    </tr>
    <tr>
      <td><strong>Z-DNA</strong></td>
      <td>Left-handed helix, zig-zag backbone, deep minor groove, no major groove.</td>
      <td>Targeted by specialized biological regulators and specific intercalators.</td>
    </tr>
    <tr>
      <td><strong>G-Quadruplexes</strong></td>
      <td>Four-stranded G-rich knots found in oncogene promoters/telomeres.</td>
      <td>Stabilized by planar molecules to lock/silence cancer genes.</td>
    </tr>
    <tr>
      <td><strong>Holliday Junctions</strong></td>
      <td>Four-way DNA cross-structures formed during replication/repair.</td>
      <td>Hyper-stabilized by targeted drugs to induce fatal genomic instability.</td>
    </tr>
    <tr>
      <td><strong>Phosphate Backbone</strong></td>
      <td>Highly negatively charged polyanion exterior.</td>
      <td>Electrostatic attraction of positively charged drugs (initial docking phase).</td>
    </tr>
  </tbody>
</table>

<h2>2. DNA-Drug Interactions</h2>


<p><strong>DNA-drug interactions</strong> are of paramount importance in biology and pharmacology because DNA is the primary repository of cellular instructions, governing all fundamental life processes. By physically or chemically engaging with DNA, drugs can disrupt essential biological functions such as <strong>gene transcription</strong> (the process of copying DNA into RNA), <strong>DNA replication</strong> (copying the genome for cell division), and overall genome stability.</p>

<p>Therapeutically, this disruption is the foundational mechanism for many clinical agents used in oncology, virology, and antimicrobial therapy. In cancer, for example, DNA-binding drugs selectively induce cell cycle arrest or programmed cell death (<dfn>apoptosis</dfn>) in rapidly dividing tumor cells, which lack the robust repair mechanisms of healthy cells. Furthermore, targeting specific, complex DNA structures offers a pathway to shut off "undruggable" cancer-driving proteins (such as MYC or KRAS) directly at the genetic level, preventing the disease-causing proteins from ever being manufactured.</p>

<p>DNA-drug interactions are generally classified into distinct mechanisms based on how they chemically or physically engage with their target.</p>

<h3>2.1. Covalent Binding (Irreversible)</h3>

<p>Covalent interactions involve the irreversible formation of strong chemical bonds between the drug and the DNA molecule. This drastically and permanently alters the DNA's physical structure and its biological function.</p>




<h4>2.1.1 Alkylation</h4>
<figure class="science-figure" data-id="Figure 6" data-clean-src="${f027_006}">
  <img src="${f027_006}" alt="Mechanism of DNA alkylation at the N7 position of guanine" />
  <figcaption>Alkylating agents predominantly attack the electron-rich N7 position of guanine bases.</figcaption>
</figure>
<p><strong>Mechanism:</strong> Alkylating agents act by transferring alkyl groups to <dfn>nucleophilic centers</dfn> (highly electron-rich atoms capable of forming new bonds) on DNA bases. The most common target is the N7 position of the guanine base. This chemical modification causes severe damage, including DNA fragmentation, nucleotide mispairing during replication, and the formation of cross-links. These cross-links can be between the two opposite strands (inter-strand) or on the same strand (intra-strand), acting like a physical padlock that prevents the two DNA strands from unwinding and separating during replication and transcription.</p>
<p><strong>Examples:</strong> <b>Nitrogen mustards</b> (e.g., mechlorethamine, cyclophosphamide), busulfan, and mitomycin C.</p>

<h4>2.1.2 Metal Coordination</h4>

<figure class="science-figure" data-id="Figure 7" data-clean-src="${f027_007}">
  <img src="${f027_007}" alt="Diagram of the Cisplatin mechanism of action showing cellular uptake, aquation, nuclear entry, formation of DNA adducts, and resulting apoptosis." />
  <figcaption><strong>Mechanism of action of the chemotherapeutic drug Cisplatin.</strong> Cisplatin enters the cell's cytoplasm through passive diffusion or active transport via the CTR1 transporter. Once inside, it undergoes aquation (the replacement of a chloride ligand with a water molecule), forming the active aquated cisplatin complex. This highly reactive species then enters the nucleus and binds to DNA, creating intra-strand cross-links (Cisplatin DNA adducts) primarily between adjacent guanine bases. These bulky physical roadblocks stall DNA polymerase during replication, prevent DNA repair mechanisms, and ultimately trigger cell cycle arrest and programmed cell death (apoptosis).</figcaption>
</figure>
<p><strong>Mechanism:</strong> Certain heavy metal-based drugs coordinate with the nitrogen and oxygen atoms of the DNA nucleobases, forming incredibly stable complexes.</p>
<p><strong>Examples:</strong> Cisplatin and other platinum-based drugs form rigid 1,2-intrastrand cross-links, predominantly between two adjacent guanine bases on the same DNA strand. This bulky cross-link induces a sharp bend in the DNA double helix. This distorted shape stalls the cell's replication machinery and sends an unrepairable damage signal to the cell, forcing it to undergo apoptosis. This specific mechanism revolutionized the clinical treatment of testicular and ovarian cancers.<sup><a href="#ref2">2</a></sup></p>


<h3>2.2 Non-Covalent Binding (Reversible)</h3>

<p>Unlike covalent modifiers, non-covalent interactions do not form permanent chemical bonds. They are generally reversible and are stabilized by a combination of weaker physical forces, including hydrogen bonding, van der Waals forces, hydrophobic (water-repelling) effects, and pi-pi stacking (attractive interactions between aromatic rings).</p>




<h4>2.2.1 Intercalation</h4>
<p><strong>Mechanism:</strong> This occurs when a flat, planar, heteroaromatic molecule slides—or intercalates—like a slice of cheese in a sandwich directly between adjacent base pairs of the DNA double helix. This intrusive action forces the native DNA structure to unwind, elongates the helix, and physically blocks the progression of essential enzymes like RNA and DNA polymerases.</p>

<figure class="science-figure" data-id="Figure 8" data-clean-src="${f027_008}">
  <img src="${f027_008}" alt="Chemical structure of doxorubicin and a molecular model showing its intercalation into a DNA double helix." />
  <figcaption><strong>DNA intercalation by Doxorubicin.</strong> The diagram illustrates the chemical structure of the anthracycline antibiotic doxorubicin (left). On the right, molecular models demonstrate the mechanism of action: doxorubicin (DOX, highlighted in green) slips or "intercalates" itself directly between the stacked, planar base pairs of the DNA double helix to form a DOX-DNA complex. This physical insertion distorts the DNA backbone, preventing DNA replication and transcription, and poisons the enzyme topoisomerase II, leading to cell death in targeted cancer cells.</figcaption>
</figure>
<p><strong>Examples:</strong> Doxorubicin and daunorubicin are potent anthracycline antibiotics that intercalate DNA. Additionally, they trap and inhibit the enzyme topoisomerase II (which normally relieves DNA supercoiling), leading to the permanent and lethal fragmentation of the tumor genome. Actinomycin D is another classic intercalator that inserts specifically at G-C base pairs to block chain elongation by RNA polymerase.</p>

<h4> 2.2.2 Groove Binding</h4>
<p><strong>Mechanism:</strong> The natural twist of the DNA double helix creates two indentations: the major groove and the minor groove. Small molecules can sit seamlessly within these grooves. Minor groove binders are often crescent-shaped, matching the curve of the groove's floor. They exhibit a very strong preference for regions rich in Adenine-Thymine (A-T) base pairs. This is because the 2-amino group of guanine protrudes into the minor groove, acting as a <dfn>steric blocker</dfn> (a physical spatial barrier) in G-C rich regions.</p>
<p><strong>Examples:</strong> The natural products netropsin and distamycin are classic minor groove binders.</p>

<h4>2.2.3 Electrostatic Interactions</h4>
<p><strong>Mechanism:</strong> The exterior sugar-phosphate backbone of DNA is highly negatively charged. Consequently, positively charged (cationic) drug molecules are naturally and strongly attracted to it. While electrostatic attraction is rarely the sole mechanism of drug action, it acts as a crucial "first step," reeling the drug in toward the DNA so it can subsequently dock into a groove or intercalate between bases.</p>

<h3>2.3. DNA Cleavage</h3>

<p>Some drugs possess the aggressive ability to act as chemical scissors, directly breaking the sugar-phosphate chains of the DNA backbone.</p>
<figure class="science-figure" data-id="Figure 9" data-clean-src="${f027_009}">
  <img src="${f027_009}" alt="Schematic illustration of the bleomycin mechanism of action, detailing cellular uptake, activation via iron and oxygen, DNA cleavage, and its distinct chemical functional domains." />
  <figcaption><strong>Figure 9: Mechanism of action and molecular structure of Bleomycin.</strong> The top panel maps the cellular activity of the glycopeptide antibiotic bleomycin. Upon entering the cell, bleomycin requires a metal cofactor—typically iron, Fe(II)—and oxygen (O<sub>2</sub>) to become an "activated bleomycin" complex. This highly reactive species acts like miniature chemical scissors, binding to DNA and causing destructive single- and double-strand breaks (DNA cleavage), which forces the cancer cell into apoptosis (programmed cell death). Secondary cellular interactions that lead to inflammation and fibrosis (a major clinical side effect in the lungs) are also shown. The bottom panel breaks down bleomycin's chemical structure into its specialized functional zones: a DNA complexing domain that anchors it to the DNA double helix, and a DNA cleavage domain that tightly holds the reactive metal ion precisely where the damage needs to be inflicted.</figcaption>
</figure>

<p><strong>Examples:</strong> Bleomycin is a complex glycopeptide that contains specific domains to bind DNA and separate domains to <dfn>chelate</dfn> (tightly grip like a molecular claw) transition metals, usually iron (Fe<sup>2+</sup>). Once bound to the DNA, it reacts with surrounding oxygen to form a highly reactive complex. This complex abstracts hydrogen atoms directly from the DNA backbone, producing free radicals that completely sever the DNA chain. Similarly, enediyne antibiotics (like neocarzinostatin) cause oxygen-dependent cleavage of the DNA phosphate backbone via highly reactive diradical intermediates.</p>


<h2>3. Databases</h2>

<h3>3.1 <a href="https://nakb.org/">Nucleic Acid Database</a> (NDB)</h3>
<p>The <strong>Protein Data Bank (PDB)</strong> is the primary worldwide archive of three-dimensional (3D) structural data for biological macromolecules. It provides experimentally determined, high-resolution structures of DNA, proteins, and their complexes with <dfn>ligands</dfn> (smaller binding molecules, such as drugs), usually obtained via techniques like X-ray crystallography, Nuclear Magnetic Resonance (NMR) spectroscopy, or Cryo-Electron Microscopy (Cryo-EM). Parallel to this, the <strong>Nucleic Acid Database (NDB)</strong> serves as a highly specific repository dedicated solely to high-resolution structural information regarding DNA, RNA, and their associated complex structures.</p>


<h3>3.2 <a href="https://dgidb.org/">DGIdb</a> (Drug-Gene Interaction Database)</h3>
<p><strong>DGIdb</strong> is a highly searchable database focusing purely on drug-gene interactions. It is particularly useful in oncology for identifying specific genes or gene products (such as <dfn>cancer driver genes</dfn> responsible for tumor growth) that are predicted to interact with targeted therapies.</p>


<h2>4. Computational Tools for DNA-Drug Interactions</h2>

<p>Several useful web servers and computational tools provide services specifically tailored to predicting, modeling, and analyzing DNA-drug interactions. These platforms range from raw 3D structural prediction to <strong>molecular docking</strong> (computational simulations that predict how a drug orientates when bound to a target) and interaction energy calculations.</p>

<p>Here is a categorized list of useful web servers and computational tools:</p>

<h2>4.1. Specialized DNA-Drug Interaction & Docking Servers</h2>


<h3><a href="https://scfbio-iitd.res.in/software/drugdesign/preddictanew.jsp">PreDDICTA</a> (Drug-DNA Interaction Energy)</h3>
<p><strong>PreDDICTA</strong> is a specialized web tool that provides a rapid computational method for evaluating potential lead drug candidates. It works by calculating the drug-DNA interaction energy directly from a single structure, allowing researchers to bypass lengthy and computationally expensive <strong>Molecular Dynamics (MD) simulations</strong> (simulations that mathematically model the physical movements of atoms over time).</p>

<h3><a href="https://scfbio-iitd.res.in/dock/dnadock.jsp">DnaDOCK</a></h3>
<p><strong>DnaDOCK</strong> is a dedicated all-atom, energy-based docking tool designed specifically for DNA-ligand interactions. It uses a <strong>Monte Carlo algorithm</strong>—a computational method that uses repeated random sampling to explore various possible spatial orientations (poses)—to find the lowest energy, and therefore most stable, fit for a drug within the DNA helix.</p>

<h3><a href="https://rdock.github.io/">rDock</a></h3>
<p><strong>rDock</strong> is a fast, open-source molecular docking program originally developed for High Throughput Virtual Screening (HTVS). It is specifically engineered to dock small molecules against nucleic acids (both DNA and RNA) as well as proteins, making it highly versatile for nucleic acid-targeted drug discovery.</p>


<h2>4. Pharmacokinetics and Drug-Likeness Servers (ADMET)</h2>

<p>Once a DNA-interacting drug candidate is successfully identified and structurally modeled, its chemical properties must be rigorously evaluated for actual clinical viability in the human body.</p>



<h3>SwissADME</h3>
<p><strong>SwissADME</strong> is a free, comprehensive web tool that provides robust predictive models to evaluate a molecule's pharmacokinetics (how the body affects the drug). It calculates properties such as drug-likeness, water solubility, and overall medicinal chemistry friendliness.</p>

<h3>pkCSM</h3>
<p><strong>pkCSM</strong> is a powerful web server utilized to evaluate the synthetic accessibility (how easily the drug can be manufactured in a lab) and the complete <strong>ADMET</strong> profile of proposed drug candidates. ADMET stands for:</p>
<ul>
  <li><strong>Absorption:</strong> How the drug enters the bloodstream.</li>
  <li><strong>Distribution:</strong> How the drug travels to the target tissues.</li>
  <li><strong>Metabolism:</strong> How the body breaks the drug down.</li>
  <li><strong>Excretion:</strong> How the drug is removed from the body.</li>
  <li><strong>Toxicity:</strong> The drug's potential poisonous effects on healthy cells.</li>
</ul>



    </article>


  `,
};

export default article;
